Home > Adults > Diabetes >

Diabetic Eye Screening

Checked: 24-07-2024 by Vicky Ryan Next Review: 23-07-2026

Service Overview

InHealth Intelligence deliver the Diabetic Eye Screening Programme across BNSSG. Please use the contact information to speak to the Bookings, Failsafe or Support Service teams:

Bookings - 0117 405 5000 or enquiries.bnssgdesp@nhs.net

Failsafe - 0117 405 7924 or hil.bnssgfailsafe@nhs.net

Support Services – 01270 527373 or supportdesk@inhealth-intelligence.com

Each BNSSG GP Practice has been contacted about setting up a Data Sharing Agreement. Once signed and returned Practices can start using the new online system to make referrals and download the result reports. Please contact Support Services to request a copy of the Data Sharing Agreement or to ask further questions using the contact information above.

Diabetic Eye Screening leaflets are available in English, Arabic, Bengali, Chinese, Gujarati, Hindi, Polish, Portuguese, Punjabi, Romanian, Urdu and Ukrainian. This leaflet is also available in an Easy Read format.

Referral

Practices are no longer required to send manual referrals to the Programme as the data is collected monthly via GP2DRS as long as they have been coded accordingly in EMIS and action is taken within the Spectra software.

Referral criteria

New patients and new to surgery patients aged 12+
Type 1, Type 2 or MODY diabetes
Registered with a GP in Bristol, North Somerset or South Gloucestershire
No referral required for gestational diabetes.

Please see the attached exclusions document for Determining Suitability of patients for Diabetic Eye Screening

If the practice has agreed to the monthly GP2DRS extraction, then InHealth Intelligence will be notified of newly diagnosed patients, which will require the Practice logging onto the software to review and confirm these patients are suitable for screening. For Practices who haven't signed the Data sharing agreement, newly diagnosed patients are being added by the Corporate DESP Project Officers until such time as a data sharing agreement has been signed.

Efforts are made to ensure the accuracy and agreement of these guidelines, including any content uploaded, referred to or linked to from the system. However, BNSSG ICB cannot guarantee this. This guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer, in accordance with the mental capacity act, and informed by the summary of product characteristics of any drugs they are considering. Practitioners are required to perform their duties in accordance with the law and their regulators and nothing in this guidance should be interpreted in a way that would be inconsistent with compliance with those duties.

Information provided through Remedy is continually updated so please be aware any printed copies may quickly become out of date.